Document Finishing by Wordzworth
Document Finishing by Wordzworth
Document Finishing by Wordzworth
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
www.mpbio.com<br />
CATALOG<br />
NUMBER<br />
CYCLOHEXIMIDE READY MADE<br />
Antibiotic solution<br />
Concentration: Approx. 100 mg/ml in DMSO (0.2 um filtered),<br />
microbial solution.<br />
Cycloheximide is an antibiotic product. Its main biological activity is<br />
translation inhibition in eukaryotes. The resulting inhibition of protein<br />
synthesis leads to cell growth arrest and death. Cycloheximide is<br />
used for selection of Cycloheximide resistant yeast and fungi strains,<br />
controlled inhibition systhesis for detection of short-lived proteins and<br />
superinduction of protein apoptosis induction or facilitation of apoptosis<br />
induction <strong>by</strong> death receptors.<br />
0 TO 5°C 66-81-9<br />
199520 1 ml<br />
N 6 -CYCLOHEXYLADENOSINE<br />
(CHA)<br />
C16H23N5O4<br />
RT MW 349.4 36396-99-3<br />
153748 10 mg<br />
CYCLOHEXYLAMINE<br />
Free Base<br />
Purity: 98-99%<br />
1 ml = 0.87 g<br />
C6H13N<br />
RT MW 99.2 108-91-8<br />
150745<br />
25 ml<br />
N-CYCLOHEXYLMALEIMIDE<br />
Crystalline<br />
RT 1631-25-0<br />
101461 5 g<br />
1,6-bis-(CYCLOHEXYLOXIMINO-<br />
CARBONYLAMINO)-HEXANE<br />
(RHC-80267)<br />
Purity: 98%<br />
Specifically blocks diacylglycerol (DAG) lipase activity in various cell<br />
lines of multiple species.<br />
Ref.: 1. Balsinde, J., et al., J. Biol. Chem., 266: 15638 (1991). 2.<br />
Southerland, C.A. and Amin, D., et al., ibid., 257: 14006 (1982). 3.<br />
Lindlisbacher, B., et al., J. Neurochem., 54: 1247 (1990). 4. Natarajan,<br />
R., et al., Biochem. Biophys. Res. Commun., 156: 171 (1988).<br />
RT MW 394.6<br />
159011 10 mg<br />
CYCLO(HIS-PHE)<br />
C15H16N4O2<br />
-20 TO 0°C MW 284.3 56586-95-9<br />
153085 5 mg<br />
CYCLOPENTANE<br />
Purity: 97%<br />
1 ml = approx. 0.75 g<br />
C5H10<br />
0 TO 5°C MW 70.1 287-92-3<br />
150747 100 ml<br />
500 ml<br />
Biochemicals<br />
Alphabetical List<br />
CATALOG<br />
NUMBER<br />
CYCLOPENTANONE<br />
Purity: 99+%<br />
1 ml = approx. 0.95 g<br />
C5H8O<br />
RT MW 84.1 120-92-3<br />
150748 50 ml<br />
500 ml<br />
8-CYCLOPENTYL-1,3-DIMETHYLXANTHINE<br />
(8-Cyclopentyltheophylline)<br />
A1 adenosine receptor antagonist.<br />
C12H16N4O2<br />
RT MW 248.3 35873-49-5<br />
153746<br />
8-CYCLOPENTYL-1,3-DIPROPYLXANTHINE<br />
(DPCPX, 1,3-Dipropyl-8-cyclopentylxanthine)<br />
A1 adenosine receptor antagonist.<br />
C16H24N4O2<br />
RT MW 305.4 102146-07-6<br />
153745<br />
25 mg<br />
CYCLOPHILIN A<br />
(Peptidylproline cis-trans-isomerase)<br />
Human, Recombinant<br />
Purity: >90%<br />
Expressed in E. coli and supplied in 20 mM Tris-HCl, pH 7.8.<br />
Accelerates protein folding <strong>by</strong> catalyzing the cis-trans-isomeration of<br />
x-pro-peptide bonds. Will bind to cyclosporins.<br />
Ref.: 1. Kunz, J. and Hall, M.M., Trends in Biochem. Sci., 18: 334<br />
(1993).<br />
2. Fruman, D.A., et al., FASEB J., 8: 391 (1994).<br />
0 TO 5°C MW ~18,000 95076-93-0<br />
159910 100 µg<br />
CYCLOPHOSPHAMIDE<br />
Monohydrate<br />
Purity: 98+%<br />
Cancer research tool.<br />
C7H15Cl2N2O2P • H2O<br />
0°C MW 336.4 18172-33-3<br />
158895<br />
25 mg<br />
0 TO 5°C MW 279.1 6055-19-2<br />
150749 1 g<br />
5 g<br />
10 g<br />
25 g<br />
CYCLOPIAZONIC ACID<br />
From: Penicillium species<br />
Purity: 98%<br />
Intracellular Ca 2+ release inducer. Inhibits endoplasmic reticulum Ca 2+ -<br />
ATPase. Highly selective for sarcoplasmic reticulum Ca 2+ -ATPase.<br />
Ref.: 1. Demaurex, N., et al., J. Biol. Chem., 267: 2318 (1992). 2.<br />
Goeger, D.E., et al., Biochem. Pharmacol., 37: 978 (1988). 3. Seidler,<br />
N.W., et al., J. Biol. Chem., 264: 17816 (1989).<br />
C20H20N2O3<br />
5 mg<br />
10 mg<br />
50 mg<br />
www.mpbio.com To place an order 1.800.854.0530, fax 1.800.334.6999<br />
165
Change language